Elmiron is utilized to treat a condition known as interstitial cystitis, better known as “painful bladder syndrome.” It is also prescribed for osteoarthritis in humans as well as elderly dogs and horses. In 2018 and 2019, authors published an article in the American Academy of Ophthalmology in which they described patients of Elmiron experiencing pigmentary maculopathy of unclear cause following chronic exposure to Elmiron (pentosan polysulfate sodium) for interstitial cystitis.
Maculopathy is a general term referring to any pathological condition that affects the macula, the central portion of the retina upon which visual acuity and sensitivity depends. Types of Maculopathy include age related Macular Degeneration, Cellophane Maculopathy, and Malattia Leventinese.
The form of Macular Degeneration that has been linked with is identified as “pigmentary maculopathy of unknown etiology”. It is a Macular injury with no known cause. Presentation of the condition differs slightly from one patient to another, but symptoms include Parafoveal Pigmented Deposits, Vitelliform Deposits, and Retinal Pigment Epithelium Atrophy. Other side effects of Elmiron include blurred vision, difficulty reading, distorted vision, eye pain, issues adjusting to darkness, vision disturbances, and vision loss.
If you have suffered maculopathy caused by Elmiron, you are eligible to file a lawsuit or join a class action lawsuit. To file a lawsuit, contact and Elmiron Attorney to start your case against Janssen Pharmaceuticals.
If you or a loved one have suffered vision impairments due to taking the bladder medication Elmiron, contact us for a free consultation. You may be entitled to recover money for pain and suffering, medical expenses, and lost wages. Contact Chhabra Gibbs & Herrington PLLC today by calling 601-948-8005 or you can use our free live chat.
